|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：D206090 |
| 產(chǎn)品名稱：N-De-boc 6-Hydroxy-7-epi Docetaxel 12-Acetate |
| 產(chǎn)品CAS： |
| 規(guī)格含量：1mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
D206090 |
| 名稱: |
N-De-boc 6-Hydroxy-7-epi Docetaxel 12-Acetate |
| 別名: |
(3S,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-Amino-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-3,4,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H,7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl Diacetate; |
| 分子式: |
C??H??NO?? |
| 分子量: |
765.8 |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
N-De-boc 6-Hydroxy-7-epi Docetaxel 12-Acetate is an intermediate used in the synthesis of 6-Oxo-7-epi Docetaxel (Technical Grade) (O870058), which is a Docetaxel impurity. Taxol derivatives are useful for the same cancers for which Taxol (Paclitaxel-P132500) has been shown active, including human ovarian cancer, breast cancer, and malignant melanoma as well as lung cancer, gastric cancer, colon cancer, head and neck cancer, and leukemia. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
